Table 4.

Effectiveness of ‘Check-In’ on incidence of COPD, diabetes mellitus, disorder of the thyroid gland, hypertension and hypercholesterolaemia

	n (%)		Effectiveness (‘Check-In’ vs Usual care)
	‘Check-In’ group	Usual care group	OR (95% CI)	P value
Any new chronic condition*
Per protocol, n=919	82 (23)	120 (22)	1.05 (0.77 to 1.45)	0.75
ITT, n=1104	125 (23)	120 (22)	1.07 (0.80 to 1.42)	0.65
Hypertension
Per protocol, n=704	40 (14)	60 (14)	1.01 (0.66 to 1.56)	0.96
ITT, n=856	55 (13)	60 (14)	0.88 (0.60 to 1.31)	0.54
Hypercholesterolaemia
Per protocol, n=752	13 (4)	20 (4)	1.00 (0.49 to 2.05)	0.99
ITT, n=908	18 (4)	20 (4)	0.90 (0.47 to 1.73)	0.76
COPD
Per protocol, n=711	19 (7)	23 (5)	1.24 (0.66 to 2.31)	0.51
ITT, n=844	32 (8)	23 (5)	1.44 (0.83 to 2.50)	0.2
Diabetes mellitus
Per protocol, n=604	8 (3)	15 (4)	0.74 (0.31 to 1.76)	0.49
ITT, n=720	14 (4)	15 (4)	0.89 (0.42 to 1.87)	0.76
Hypothyroidism†
Per protocol, n=919	–	–	–	–
ITT, n=840	–	–	–	–
Hyperthyroidism†
Per protocol, n=878	–	–	–	–
ITT, n=1051	–	–	–	–
Depression
Per protocol, n=789	12 (4)	9 (2)	2.05 (0.85 to 4.91)	0.11
ITT, n=944	25 (5)	9 (2)	2.90 (1.34 to 6.29)	0.007

The analyses are performed per protocol and as ITT.

*Hypertension if no hypertension at baseline, hypercholesterolaemia if no hypercholesterolaemia at baseline, COPD if no COPD at baseline, diabetes if no diabetes at baseline, hypothyroidism if no hypothyroidism at baseline, hyperthyroidism if no hyperthyroidism at baseline or depression if no depression at baseline.

†Too few in each group to report for ethical reasons.

COPD, chronic obstructive pulmonary disease; ITT, intention to treat.